STATE STREET CORP - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 57 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q1 2022$458,000
-30.6%
412,7680.0%0.00%
Q4 2021$660,000
-34.2%
412,7680.0%0.00%
Q3 2021$1,003,000
+304.4%
412,768
+427.8%
0.00%
Q2 2021$248,000
+359.3%
78,200
+373.5%
0.00%
Q4 2019$54,000
+12.5%
16,5160.0%0.00%
Q3 2019$48,000
+20.0%
16,5160.0%0.00%
Q2 2019$40,00016,5160.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q3 2023
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 1,854,278$6,638,0003.61%
Asymmetry Capital Management, L.P. 739,812$2,649,0001.21%
Affinity Asset Advisors, LLC 625,000$2,238,0001.19%
Tri Locum Partners LP 728,710$2,609,0000.95%
Boxer Capital, LLC 6,226,673$22,291,0000.72%
DAFNA Capital Management LLC 668,148$2,392,0000.71%
Vivo Capital, LLC 4,220,938$15,111,0000.67%
Delphi Management Partners VIII, L.L.C. 256,734$919,0000.60%
SILVERARC CAPITAL MANAGEMENT, LLC 280,000$1,002,0000.58%
Rubric Capital Management LP 1,853,417$6,635,0000.49%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders